LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. TI=Current review of Brugada syndrome: from epidemiology to treatment
  2. AU="Gherghina, Ştefan Cristian"

Suchergebnis

Treffer 1 - 3 von insgesamt 3

Suchoptionen

  1. Artikel ; Online: Current review of Brugada syndrome: from epidemiology to treatment.

    Khan, Aslam / Mittal, Suneet / Sherrid, Mark V

    Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology

    2009  Band 9 Suppl 2, Seite(n) 12–16

    Abstract: ... Treatment strategies for Brugada syndrome are evolving. Currently, the implanted cardioverter defibrillator ... ICD) is the only proven treatment for Brugada syndrome. Candidates for ICD include patients include ... Brugada syndrome is a genetic cause of sudden cardiac arrest characterized by abnormal ...

    Abstract Brugada syndrome is a genetic cause of sudden cardiac arrest characterized by abnormal electrocardiographic (ECG) pattern in the right precordial leads either at rest or after provocation. In this condition, sudden death may occur due to polymorphic ventricular tachycardia or ventricular fibrillation. In approximately 30% of patients, sudden cardiac arrest is the initial clinical manifestation of Brugada syndrome. Treatment strategies for Brugada syndrome are evolving. Currently, the implanted cardioverter defibrillator (ICD) is the only proven treatment for Brugada syndrome. Candidates for ICD include patients include those with the type 1 ECG pattern or who have been successfully resuscitated from sudden death or have had unexplained syncope.
    Mesh-Begriff(e) Arrhythmias, Cardiac/genetics ; Arrhythmias, Cardiac/mortality ; Arrhythmias, Cardiac/therapy ; Brugada Syndrome/epidemiology ; Brugada Syndrome/genetics ; Brugada Syndrome/mortality ; Brugada Syndrome/therapy ; Death, Sudden, Cardiac/epidemiology ; Death, Sudden, Cardiac/etiology ; Defibrillators, Implantable ; Electrocardiography ; Humans ; Risk Factors ; Tachycardia, Ventricular/genetics ; Tachycardia, Ventricular/mortality ; Tachycardia, Ventricular/therapy
    Sprache Englisch
    Erscheinungsdatum 2009-12
    Erscheinungsland Turkey
    Dokumenttyp Journal Article
    ZDB-ID 2278670-3
    ISSN 1308-0032 ; 1302-8723
    ISSN (online) 1308-0032
    ISSN 1302-8723
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Atrial fibrillation in Brugada syndrome: Current perspectives.

    Vlachos, Konstantinos / Mascia, Giuseppe / Martin, Claire A / Bazoukis, George / Frontera, Antonio / Cheniti, Ghassen / Letsas, Konstantinos P / Efremidis, Micheal / Georgopoulos, Stamatis / Gkalapis, Charis / Duchateau, Josselin / Parmbrun, Thomas / Derval, Nicholas / Hocini, Mélèze / Haissaguerre, Michel / Jais, Pierre / Sacher, Frédéric

    Journal of cardiovascular electrophysiology

    2020  Band 31, Heft 4, Seite(n) 975–984

    Abstract: ... in AF treatment. In this review, we aim to present the current perspectives regarding the genetics ... The incidence of atrial fibrillation (AF) in Brugada syndrome (BrS) has been reported at between 9 ... arrhythmias in BrS such as quinidine or invasive treatment with pulmonary vein isolation (PVI) may be useful ...

    Abstract The incidence of atrial fibrillation (AF) in Brugada syndrome (BrS) has been reported at between 9% and 53% by different series, but the true prevalence is unknown. However, AF may be the presenting feature in some patients. The underlying mechanisms for AF may be a combination of multiple factors, genetic or acquired, that may impact upon autonomic function, atrial structure, and conduction velocities or other unknown factors. The presence of AF has been associated with a more malignant course, with a greater incidence of syncope and ventricular arrhythmias, thus acting as marker of more advanced disease. Regarding the management of patients with AF, antiarrhythmic drugs effective in preventing malignant arrhythmias in BrS such as quinidine or invasive treatment with pulmonary vein isolation (PVI) may be useful in AF treatment. In this review, we aim to present the current perspectives regarding the genetics, pathophysiology, management, and prognosis of AF in patients with BrS.
    Mesh-Begriff(e) Ablation Techniques ; Action Potentials/drug effects ; Anti-Arrhythmia Agents/therapeutic use ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/epidemiology ; Atrial Fibrillation/physiopathology ; Brugada Syndrome/diagnosis ; Brugada Syndrome/epidemiology ; Brugada Syndrome/physiopathology ; Brugada Syndrome/therapy ; Heart Conduction System/drug effects ; Heart Conduction System/physiopathology ; Heart Conduction System/surgery ; Heart Rate/drug effects ; Humans ; Prevalence ; Risk Factors ; Treatment Outcome
    Chemische Substanzen Anti-Arrhythmia Agents
    Sprache Englisch
    Erscheinungsdatum 2020-01-29
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review
    ZDB-ID 1025989-2
    ISSN 1540-8167 ; 1045-3873
    ISSN (online) 1540-8167
    ISSN 1045-3873
    DOI 10.1111/jce.14361
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Current review of Brugada syndrome

    Aslam Khan / Suneet Mittal / Mark V. Sherrid

    Anadolu Kardiyoloji Dergisi, Vol 09, Iss 08, Pp 12-

    from epidemiology to treatment

    2009  Band 16

    Abstract: ... Treatment strategies for Brugada syndrome are evolving. Currently, the implanted cardioverter defibrillator ... ICD) is the only proven treatment for Brugada syndrome. Candidates for ICD include patients include ... Brugada syndrome is a genetic cause of sudden cardiac arrest characterized by abnormal ...

    Abstract Brugada syndrome is a genetic cause of sudden cardiac arrest characterized by abnormal electrocardiographic (ECG) pattern in the right precordial leads either at rest or after provocation. In this condition, sudden death may occur due to polymorphic ventricular tachycardia or ventricular fibrillation. In approximately 30% of patients, sudden cardiac arrest is the initial clinical manifestation of Brugada syndrome. Treatment strategies for Brugada syndrome are evolving. Currently, the implanted cardioverter defibrillator (ICD) is the only proven treatment for Brugada syndrome. Candidates for ICD include patients include those with the type 1 ECG pattern or who have been successfully resuscitated from sudden death or have had unexplained syncope.
    Schlagwörter Brugada syndrome ; implantable cardioverter defibrillator ; sudden cardiac death ; Diseases of the circulatory (Cardiovascular) system ; RC666-701 ; Specialties of internal medicine ; RC581-951 ; Internal medicine ; RC31-1245 ; Medicine ; R ; DOAJ:Cardiovascular ; DOAJ:Medicine (General) ; DOAJ:Health Sciences
    Thema/Rubrik (Code) 610
    Sprache Türkisch
    Erscheinungsdatum 2009-12-01T00:00:00Z
    Verlag Aves Yayincilik
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang